Endovascular therapy for ischemic stroke with perfusion-imaging selection.

By B. Campbell, P. Mitchell, T. Kleinig, H. Dewey, L. Churilov, N. Yassi, B. Yan, R. Dowling, M. Parsons, T. Oxley and 26 more. New England Journal of Medicine, 2015

5,311 citations recorded by the source corpus.

Subfields: Epidemiology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/958d215dc29115cd75a8a7c42b5d9d51cfcae0f3

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. E. Lindsay
2. B. Campbell
3. M. Goyal
4. A. van der Lugt
5. D. Dippel
6. Pengfei Yang
7. B. Menon
8. C. Majoie

Citations in the corpus

• Multisociety Consensus Quality Improvement Revised Consensus Statement for Endovascular Therapy of Acute Ischemic Stroke (2018, neutral): “The Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands (MR CLEAN) trial had a minimum NIHSS score of 2 and Extending the Time for Thrombolysis in Emergency Neurological Deficits -Intra-arterial (EXTEND-IA) had no NIHSS score limits, but, give”
• Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct (2018, background): “Second segment of middle cerebral artery 2 (2) 3 (3)”
• Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis. (2016, methodology): “16 Efficacy outcomes analyzed at 3 months were (1) degree of disability, assessed across 6 levels of the modified Rankin Scale (mRS), with ranks 5 and 6 combined into a single worst outcome rank; (2) functional independence, defined as mRS scores of 0 through 2; and (3) excellent outcome, defined as”